GOLDEN GAIT THERAPEUTICS

Sobre la Empresa

Nombre legal: GOLDEN GAIT THERAPEUTICS
País de registro: Spain
Dirección: Edificio Tandem, Paseo Miramon 170, 20014 Donostia-San Sebastian, Basque Country, Spain
Año de fundación: 2024

Descripción:

Spanish clinical-stage biotechnology company founded in 2024 at San Sebastian in the Basque Country developing GGB-1, described as the first pharmaceutical intervention aimed at reducing and preventing falls and freezing of gait in people with Parkinson's disease, which received FDA investigational new drug approval in 2025.